Alpha Wave

Activity from announced rounds

Activity in this selectionOct 23, 2026 · Asia · Jul 26, 2026

Alpha Wave is the investment-manager name used in the covered financings and connected to Alpha Wave Global’s official press and investment records.

Recorded funding activity

The recorded activity includes a lead role in Moonwalk Biosciences’ Series B for medicines targeting fat-tissue pathways in obesity and cardiometabolic disease. Other announcements concern AdvanCell’s targeted alpha radiopharmaceuticals for cancer and Ultrahuman’s wearable ring and health-testing products. These events describe the activity captured here rather than the manager’s complete allocation.

Sources
Rounds participated in
2
Confirmed lead rounds
0
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$120M
2 disclosed · full round size, not this investor’s share

By stage

Series B1
Undisclosed1

By primary sector

Healthtech2

By country

India2

Rounds

2 in this selection
Even Healthcare

Even Healthcare combines hospital care, care coordination and digital follow-up for patients in India.

$50MSeries B
Participant
Ultrahuman

Ultrahuman combines a wearable ring with app-based health insights and complementary testing.

$70MFunding round
Participant